Literature DB >> 10393456

Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.

H Watanabe1, H Sueki, T Nakada, M Akiyama, M Iijima.   

Abstract

Most cases of drug eruption caused by nonionic contrast media (NICM) reported to date have been of the erythema multiforme type. Herein we report the first case of multiple fixed drug eruption (FDE) caused by iomeprol (Iomeron(R)). A 67-year-old woman developed multiple pea-sized erythematous papules on the trunk and extremities 4 days after receiving 100 ml of iomeprol for a computed tomography examination. Some of the papules coalesced, forming 7 large plaques on the limbs. Six months later, the patient was mistakenly administered iomeprol again. On the following morning, erythematous plaques admixed with vesicles recurred at the same sites as during the previous episode. In both episodes, the lesions cleared leaving pigmentation that faded with 6 weeks. Both patch testing and an intradermal test with iomeprol on lesional pigmented skin were positive. The present case indicates that NICM may cause multiple FDE and that repeated administration of the causative agent may increase the severity of the eruption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393456     DOI: 10.1159/000018133

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

Review 1.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

Review 2.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

3.  Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.

Authors:  Ingrid Böhm; Jesus Medina; Pilar Prieto; Wolfgang Block; Hans H Schild
Journal:  Eur Radiol       Date:  2006-08-26       Impact factor: 5.315

4.  Late adverse reactions to intravascular iodine based contrast media: an update.

Authors:  Marie-France Bellin; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Olivier Clement; Gertraud Heinz-Peer; Peter Reimer; Aart van der Molen
Journal:  Eur Radiol       Date:  2011-07-16       Impact factor: 5.315

5.  Monitoring non-immediate allergic reactions to iodine contrast media.

Authors:  M J Torres; C Mayorga; J A Cornejo-Garcia; S Lopez; P Chaves; C Rondon; T Fernandez; M Blanca
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 6.  Current understanding of contrast media reactions and implications for clinical management.

Authors:  Marc J Meth; Howard I Maibach
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

7.  Fixed Drug Eruption due to Iopromide (Ultravist®).

Authors:  Sang Hee Cha; Hei Sung Kim; Jun Young Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.